Operating expenses and share based payments seem excessive for a company this size. No problems with the R&D expenses. A bit of belt tightening and some sharing of the pain with shareholders wouldn’t go astray.
Ann: Appendix 4E and Preliminary Final Report, page-2
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| CHM (ASX) Chart |
Day chart unavailable